Abrams, Marc
Dicerna Pharmaceuticals (United States)
3 papers on CoChat
Most cited papers
- Verified
Evaluation of Efficacy, Biodistribution, and Inflammation for a Potent siRNA Nanoparticle: Effect of Dexamethasone Co-treatment
Abrams, M. T., Koser, M. L., Seitzer, J., Williams, S. C., DiPietro, M. A., Wang, W., Shaw, A. W., Mao, X., Jadhav, V., Davide, J. P., et al. (2010) · Molecular Therapy
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 209
- Verified
Biodistribution of Small Interfering RNA at the Organ and Cellular Levels after Lipid Nanoparticle-mediated Delivery
Shi, B., Keough, E., Matter, A., Leander, K., Young, S., Carlini, E., Sachs, A. B., Tao, W., Abrams, M., Howell, B., et al. (2011) · Journal of Histochemistry & Cytochemistry
RNA Interference and Gene DeliveryNanoparticle-Based Drug Delivery
Cited by 125
- Verified
Inhibition of glycolate oxidase with dicer-substrate siRNA reduces calcium oxalate deposition in a mouse model of primary hyperoxaluria type 1
Dutta, C., Avitahl-Curtis, N., Pursell, N., Larsson Cohen, M., Holmes, B., Diwanji, R., Zhou, W., Apponi, L., Koser, M., Ying, B., et al. (2016) · Molecular Therapy
Kidney Stones and Urolithiasis TreatmentsRNA Interference and Gene Delivery
Cited by 81
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free